These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4092000)

  • 21. Verapamil plasma binding: relationship to alpha 1-acid glycoprotein and drug efficacy.
    McGowan FX; Reiter MJ; Pritchett EL; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):485-90. PubMed ID: 6831827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097.
    Wu J; Lorusso PM; Matherly LH; Li J
    Clin Cancer Res; 2012 Apr; 18(7):2066-79. PubMed ID: 22351688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diazepam and lidocaine plasma protein binding in renal disease.
    Grossman SH; Davis D; Kitchell BB; Shand DG; Routledge PA
    Clin Pharmacol Ther; 1982 Mar; 31(3):350-7. PubMed ID: 7037263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of plasma alpha1-acid glycoprotein concentration on the accumulation of lidocaine metabolites during continuous epidural anesthesia in infants and children.
    Kakiuchi Y; Kohda Y; Miyabe M; Momose Y
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):493-8. PubMed ID: 10543316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lidocaine protein binding in preeclampsia.
    Bottorff MB; Pieper JA; Boucher BA; Hoon TJ; Ramanathan J; Sibai BM
    Eur J Clin Pharmacol; 1987; 31(6):719-22. PubMed ID: 3556378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-related differences in the plasma protein binding of lignocaine and diazepam.
    Routledge PA; Stargel WW; Kitchell BB; Barchowsky A; Shand DG
    Br J Clin Pharmacol; 1981 Mar; 11(3):245-50. PubMed ID: 7213526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-protein binding interferences caused by the plasticizer TBEP.
    Devine JE
    Clin Biochem; 1984 Dec; 17(6):345-7. PubMed ID: 6518648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the sialylation state of alpha 1-acid glycoprotein on propranolol binding.
    Primozic S; McNamara PJ
    J Pharm Sci; 1985 Apr; 74(4):473-5. PubMed ID: 3999012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a method to measure free and bound ropivacaine in human plasma using equilibrium dialysis and hydrophilic interaction chromatography coupled to high resolution mass spectrometry.
    Abbas M; Ahmad L; Shah Y; Gill M; Watson DG
    Talanta; 2013 Dec; 117():60-3. PubMed ID: 24209310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of premedication on lignocaine-induced acute toxicity and plasma concentrations of lignocaine.
    Haasio J; Hekali R; Rosenberg PH
    Br J Anaesth; 1988 Aug; 61(2):131-4. PubMed ID: 3415882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Drug Binding to Human Serum Albumin and Alpha One Acid Glycoprotein in Diseased and Age Patient Populations.
    McNamara PJ; Meiman D
    J Pharm Sci; 2019 Aug; 108(8):2737-2747. PubMed ID: 30905706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Stargel WW; Wagner GS; Shand DG
    Ann Intern Med; 1980 Nov; 93(5):701-4. PubMed ID: 7212479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The plasma protein binding of basic drugs.
    Routledge PA
    Br J Clin Pharmacol; 1986 Nov; 22(5):499-506. PubMed ID: 3790398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction.
    David BM; Ilett KF; Whitford EG; Stenhouse NS
    Br J Clin Pharmacol; 1983 Apr; 15(4):435-41. PubMed ID: 6849779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme induction with rifampicin; lipoproteins and drug binding to alpha 1-acid glycoprotein.
    Feely J; Clee M; Pereira L; Guy E
    Br J Clin Pharmacol; 1983 Aug; 16(2):195-7. PubMed ID: 6615694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T; Thevanayagam LN; Blaschke TF; Au S; Stone JA; Jayewardene AL; Chi J; Aweeka FT
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.